nodes	percent_of_prediction	percent_of_DWPC	metapath
Glipizide—type 2 diabetes mellitus—obesity	0.505	1	CtDrD
Glipizide—PPARG—obesity	0.192	1	CbGaD
Glipizide—CYP2C9—Phentermine—obesity	0.0269	0.188	CbGbCtD
Glipizide—CYP2C9—Bupropion—obesity	0.0229	0.16	CbGbCtD
Glipizide—CYP3A4—Sibutramine—obesity	0.0206	0.144	CbGbCtD
Glipizide—CYP2C9—Cimetidine—obesity	0.0168	0.117	CbGbCtD
Glipizide—CYP3A4—Benzphetamine—obesity	0.0156	0.109	CbGbCtD
Glipizide—CYP3A4—Bupropion—obesity	0.0133	0.0929	CbGbCtD
Glipizide—CYP3A4—Orlistat—obesity	0.0108	0.0757	CbGbCtD
Glipizide—CYP3A4—Cimetidine—obesity	0.00976	0.0682	CbGbCtD
Glipizide—CYP3A4—Topiramate—obesity	0.00639	0.0446	CbGbCtD
Glipizide—PPARG—brown adipose tissue—obesity	0.003	0.229	CbGeAlD
Glipizide—KCNJ11—islet of Langerhans—obesity	0.000904	0.0689	CbGeAlD
Glipizide—ABCC8—islet of Langerhans—obesity	0.000833	0.0635	CbGeAlD
Glipizide—KCNJ11—cardiovascular system—obesity	0.000654	0.0499	CbGeAlD
Glipizide—PPARG—islet of Langerhans—obesity	0.000636	0.0485	CbGeAlD
Glipizide—ABCC8—cardiovascular system—obesity	0.000603	0.0459	CbGeAlD
Glipizide—PPARG—respiratory system—obesity	0.0006	0.0458	CbGeAlD
Glipizide—Glyburide—CPT1A—obesity	0.000574	0.772	CrCbGaD
Glipizide—ABCC8—pituitary gland—obesity	0.000533	0.0407	CbGeAlD
Glipizide—KCNJ11—adrenal gland—obesity	0.000517	0.0394	CbGeAlD
Glipizide—ABCC8—adrenal gland—obesity	0.000477	0.0363	CbGeAlD
Glipizide—PPARG—cardiovascular system—obesity	0.00046	0.0351	CbGeAlD
Glipizide—KCNJ11—endocrine gland—obesity	0.000449	0.0342	CbGeAlD
Glipizide—ABCC8—endocrine gland—obesity	0.000413	0.0315	CbGeAlD
Glipizide—PPARG—adipose tissue—obesity	0.000406	0.0309	CbGeAlD
Glipizide—PPARG—digestive system—obesity	0.000382	0.0291	CbGeAlD
Glipizide—PPARG—adrenal gland—obesity	0.000364	0.0277	CbGeAlD
Glipizide—PPARG—endocrine gland—obesity	0.000315	0.024	CbGeAlD
Glipizide—PPARG—liver—obesity	0.000284	0.0217	CbGeAlD
Glipizide—CYP2C9—cardiovascular system—obesity	0.000269	0.0205	CbGeAlD
Glipizide—CYP2C9—digestive system—obesity	0.000224	0.017	CbGeAlD
Glipizide—CYP2C9—endocrine gland—obesity	0.000185	0.0141	CbGeAlD
Glipizide—Abdominal discomfort—Bupropion—obesity	0.000172	0.00202	CcSEcCtD
Glipizide—Pancytopenia—Bupropion—obesity	0.000171	0.002	CcSEcCtD
Glipizide—Hepatitis—Orlistat—obesity	0.000171	0.002	CcSEcCtD
Glipizide—CYP3A4—digestive system—obesity	0.00017	0.013	CbGeAlD
Glipizide—Pharyngitis—Orlistat—obesity	0.000169	0.00199	CcSEcCtD
Glipizide—Vomiting—Phentermine—obesity	0.000169	0.00198	CcSEcCtD
Glipizide—Dysuria—Bupropion—obesity	0.000168	0.00197	CcSEcCtD
Glipizide—Cramps of lower extremities—Topiramate—obesity	0.000168	0.00197	CcSEcCtD
Glipizide—Rash—Phentermine—obesity	0.000167	0.00196	CcSEcCtD
Glipizide—Dermatitis—Phentermine—obesity	0.000167	0.00196	CcSEcCtD
Glipizide—CYP2C9—liver—obesity	0.000167	0.0127	CbGeAlD
Glipizide—Headache—Phentermine—obesity	0.000166	0.00195	CcSEcCtD
Glipizide—Rhinitis—Sibutramine—obesity	0.000166	0.00194	CcSEcCtD
Glipizide—Urine output increased—Topiramate—obesity	0.000165	0.00194	CcSEcCtD
Glipizide—Nausea—Phenylpropanolamine—obesity	0.000165	0.00193	CcSEcCtD
Glipizide—Hypoaesthesia—Sibutramine—obesity	0.000164	0.00193	CcSEcCtD
Glipizide—Photosensitivity reaction—Bupropion—obesity	0.000164	0.00193	CcSEcCtD
Glipizide—Pharyngitis—Sibutramine—obesity	0.000164	0.00192	CcSEcCtD
Glipizide—Hypersensitivity—Cimetidine—obesity	0.000162	0.0019	CcSEcCtD
Glipizide—Hypertonia—Topiramate—obesity	0.00016	0.00188	CcSEcCtD
Glipizide—Abnormal vision—Topiramate—obesity	0.000159	0.00187	CcSEcCtD
Glipizide—Visual impairment—Sibutramine—obesity	0.000159	0.00187	CcSEcCtD
Glipizide—Diarrhoea—Diethylpropion—obesity	0.000158	0.00185	CcSEcCtD
Glipizide—Nausea—Phentermine—obesity	0.000158	0.00185	CcSEcCtD
Glipizide—Asthenia—Cimetidine—obesity	0.000157	0.00185	CcSEcCtD
Glipizide—Jaundice—Bupropion—obesity	0.000156	0.00183	CcSEcCtD
Glipizide—Conjunctivitis—Bupropion—obesity	0.000156	0.00183	CcSEcCtD
Glipizide—Eye disorder—Sibutramine—obesity	0.000154	0.00181	CcSEcCtD
Glipizide—Sweating—Bupropion—obesity	0.000154	0.0018	CcSEcCtD
Glipizide—Dizziness—Diethylpropion—obesity	0.000153	0.00179	CcSEcCtD
Glipizide—Polyuria—Topiramate—obesity	0.000151	0.00177	CcSEcCtD
Glipizide—Diarrhoea—Cimetidine—obesity	0.00015	0.00176	CcSEcCtD
Glipizide—Chills—Sibutramine—obesity	0.000148	0.00174	CcSEcCtD
Glipizide—Eczema—Topiramate—obesity	0.000147	0.00173	CcSEcCtD
Glipizide—Arrhythmia—Sibutramine—obesity	0.000147	0.00173	CcSEcCtD
Glipizide—Vomiting—Diethylpropion—obesity	0.000147	0.00172	CcSEcCtD
Glipizide—Flatulence—Orlistat—obesity	0.000146	0.00172	CcSEcCtD
Glipizide—Rash—Diethylpropion—obesity	0.000145	0.00171	CcSEcCtD
Glipizide—Dermatitis—Diethylpropion—obesity	0.000145	0.0017	CcSEcCtD
Glipizide—Dizziness—Cimetidine—obesity	0.000145	0.0017	CcSEcCtD
Glipizide—Headache—Diethylpropion—obesity	0.000145	0.0017	CcSEcCtD
Glipizide—Rhinitis—Bupropion—obesity	0.000144	0.00169	CcSEcCtD
Glipizide—Hepatitis—Bupropion—obesity	0.000144	0.00169	CcSEcCtD
Glipizide—Hypoaesthesia—Bupropion—obesity	0.000143	0.00168	CcSEcCtD
Glipizide—Libido decreased—Topiramate—obesity	0.000143	0.00168	CcSEcCtD
Glipizide—Pharyngitis—Bupropion—obesity	0.000143	0.00168	CcSEcCtD
Glipizide—Muscle spasms—Orlistat—obesity	0.000143	0.00167	CcSEcCtD
Glipizide—Flatulence—Sibutramine—obesity	0.000142	0.00166	CcSEcCtD
Glipizide—Tension—Sibutramine—obesity	0.000141	0.00165	CcSEcCtD
Glipizide—CYP3A4—endocrine gland—obesity	0.000141	0.0107	CbGeAlD
Glipizide—Vision blurred—Orlistat—obesity	0.00014	0.00164	CcSEcCtD
Glipizide—Visual disturbance—Topiramate—obesity	0.00014	0.00164	CcSEcCtD
Glipizide—Nervousness—Sibutramine—obesity	0.00014	0.00164	CcSEcCtD
Glipizide—Vomiting—Cimetidine—obesity	0.00014	0.00164	CcSEcCtD
Glipizide—Thirst—Topiramate—obesity	0.000139	0.00163	CcSEcCtD
Glipizide—Visual impairment—Bupropion—obesity	0.000139	0.00163	CcSEcCtD
Glipizide—Rash—Cimetidine—obesity	0.000138	0.00162	CcSEcCtD
Glipizide—Dermatitis—Cimetidine—obesity	0.000138	0.00162	CcSEcCtD
Glipizide—Muscle spasms—Sibutramine—obesity	0.000138	0.00162	CcSEcCtD
Glipizide—Ill-defined disorder—Orlistat—obesity	0.000138	0.00162	CcSEcCtD
Glipizide—Headache—Cimetidine—obesity	0.000138	0.00161	CcSEcCtD
Glipizide—Nausea—Diethylpropion—obesity	0.000137	0.00161	CcSEcCtD
Glipizide—Hypoglycaemia—Topiramate—obesity	0.000136	0.00159	CcSEcCtD
Glipizide—Vision blurred—Sibutramine—obesity	0.000135	0.00159	CcSEcCtD
Glipizide—Tremor—Sibutramine—obesity	0.000135	0.00158	CcSEcCtD
Glipizide—Eye disorder—Bupropion—obesity	0.000134	0.00158	CcSEcCtD
Glipizide—Malaise—Orlistat—obesity	0.000134	0.00157	CcSEcCtD
Glipizide—Flushing—Bupropion—obesity	0.000134	0.00157	CcSEcCtD
Glipizide—Vertigo—Orlistat—obesity	0.000133	0.00156	CcSEcCtD
Glipizide—Ill-defined disorder—Sibutramine—obesity	0.000133	0.00156	CcSEcCtD
Glipizide—Hyponatraemia—Topiramate—obesity	0.000133	0.00156	CcSEcCtD
Glipizide—Diplopia—Topiramate—obesity	0.000133	0.00155	CcSEcCtD
Glipizide—Disturbance in sexual arousal—Topiramate—obesity	0.000131	0.00154	CcSEcCtD
Glipizide—Migraine—Topiramate—obesity	0.00013	0.00153	CcSEcCtD
Glipizide—Nausea—Cimetidine—obesity	0.00013	0.00153	CcSEcCtD
Glipizide—Malaise—Sibutramine—obesity	0.00013	0.00152	CcSEcCtD
Glipizide—Chills—Bupropion—obesity	0.000129	0.00151	CcSEcCtD
Glipizide—Vertigo—Sibutramine—obesity	0.000129	0.00151	CcSEcCtD
Glipizide—Syncope—Sibutramine—obesity	0.000129	0.00151	CcSEcCtD
Glipizide—Leukopenia—Sibutramine—obesity	0.000129	0.00151	CcSEcCtD
Glipizide—Arrhythmia—Bupropion—obesity	0.000129	0.00151	CcSEcCtD
Glipizide—CYP3A4—liver—obesity	0.000127	0.00968	CbGeAlD
Glipizide—Myalgia—Orlistat—obesity	0.000126	0.00148	CcSEcCtD
Glipizide—Loss of consciousness—Sibutramine—obesity	0.000126	0.00148	CcSEcCtD
Glipizide—Anxiety—Orlistat—obesity	0.000126	0.00148	CcSEcCtD
Glipizide—Discomfort—Orlistat—obesity	0.000125	0.00147	CcSEcCtD
Glipizide—Hypertension—Sibutramine—obesity	0.000124	0.00146	CcSEcCtD
Glipizide—Flatulence—Bupropion—obesity	0.000123	0.00145	CcSEcCtD
Glipizide—Tension—Bupropion—obesity	0.000123	0.00144	CcSEcCtD
Glipizide—Arthralgia—Sibutramine—obesity	0.000122	0.00144	CcSEcCtD
Glipizide—Myalgia—Sibutramine—obesity	0.000122	0.00144	CcSEcCtD
Glipizide—Anxiety—Sibutramine—obesity	0.000122	0.00143	CcSEcCtD
Glipizide—Nervousness—Bupropion—obesity	0.000122	0.00143	CcSEcCtD
Glipizide—Oedema—Orlistat—obesity	0.000121	0.00142	CcSEcCtD
Glipizide—Abdominal pain upper—Topiramate—obesity	0.000121	0.00142	CcSEcCtD
Glipizide—Discomfort—Sibutramine—obesity	0.000121	0.00142	CcSEcCtD
Glipizide—Muscle spasms—Bupropion—obesity	0.00012	0.00141	CcSEcCtD
Glipizide—Confusional state—Sibutramine—obesity	0.000118	0.00139	CcSEcCtD
Glipizide—Vision blurred—Bupropion—obesity	0.000118	0.00139	CcSEcCtD
Glipizide—Tremor—Bupropion—obesity	0.000117	0.00138	CcSEcCtD
Glipizide—Oedema—Sibutramine—obesity	0.000117	0.00138	CcSEcCtD
Glipizide—Hyperhidrosis—Orlistat—obesity	0.000117	0.00137	CcSEcCtD
Glipizide—Ill-defined disorder—Bupropion—obesity	0.000116	0.00136	CcSEcCtD
Glipizide—Shock—Sibutramine—obesity	0.000115	0.00135	CcSEcCtD
Glipizide—Thrombocytopenia—Sibutramine—obesity	0.000115	0.00135	CcSEcCtD
Glipizide—Hyperhidrosis—Sibutramine—obesity	0.000113	0.00133	CcSEcCtD
Glipizide—Malaise—Bupropion—obesity	0.000113	0.00133	CcSEcCtD
Glipizide—Vertigo—Bupropion—obesity	0.000113	0.00132	CcSEcCtD
Glipizide—Syncope—Bupropion—obesity	0.000112	0.00132	CcSEcCtD
Glipizide—Leukopenia—Bupropion—obesity	0.000112	0.00132	CcSEcCtD
Glipizide—Anorexia—Sibutramine—obesity	0.000112	0.00131	CcSEcCtD
Glipizide—Gliclazide—ALB—obesity	0.000111	0.15	CrCbGaD
Glipizide—Musculoskeletal discomfort—Orlistat—obesity	0.00011	0.0013	CcSEcCtD
Glipizide—Loss of consciousness—Bupropion—obesity	0.00011	0.00129	CcSEcCtD
Glipizide—Abdominal discomfort—Topiramate—obesity	0.00011	0.00129	CcSEcCtD
Glipizide—Insomnia—Orlistat—obesity	0.00011	0.00129	CcSEcCtD
Glipizide—Paraesthesia—Orlistat—obesity	0.000109	0.00128	CcSEcCtD
Glipizide—Pancytopenia—Topiramate—obesity	0.000109	0.00128	CcSEcCtD
Glipizide—Hypertension—Bupropion—obesity	0.000108	0.00127	CcSEcCtD
Glipizide—Dysuria—Topiramate—obesity	0.000107	0.00126	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Sibutramine—obesity	0.000107	0.00125	CcSEcCtD
Glipizide—Dyspepsia—Orlistat—obesity	0.000107	0.00125	CcSEcCtD
Glipizide—Arthralgia—Bupropion—obesity	0.000107	0.00125	CcSEcCtD
Glipizide—Myalgia—Bupropion—obesity	0.000107	0.00125	CcSEcCtD
Glipizide—Anxiety—Bupropion—obesity	0.000106	0.00125	CcSEcCtD
Glipizide—Insomnia—Sibutramine—obesity	0.000106	0.00124	CcSEcCtD
Glipizide—Discomfort—Bupropion—obesity	0.000105	0.00124	CcSEcCtD
Glipizide—Decreased appetite—Orlistat—obesity	0.000105	0.00124	CcSEcCtD
Glipizide—Paraesthesia—Sibutramine—obesity	0.000105	0.00124	CcSEcCtD
Glipizide—Gastrointestinal disorder—Orlistat—obesity	0.000105	0.00123	CcSEcCtD
Glipizide—Dyspnoea—Sibutramine—obesity	0.000105	0.00123	CcSEcCtD
Glipizide—Photosensitivity reaction—Topiramate—obesity	0.000105	0.00123	CcSEcCtD
Glipizide—Somnolence—Sibutramine—obesity	0.000104	0.00122	CcSEcCtD
Glipizide—Pain—Orlistat—obesity	0.000104	0.00122	CcSEcCtD
Glipizide—Dyspepsia—Sibutramine—obesity	0.000103	0.00121	CcSEcCtD
Glipizide—Confusional state—Bupropion—obesity	0.000103	0.00121	CcSEcCtD
Glipizide—Oedema—Bupropion—obesity	0.000102	0.0012	CcSEcCtD
Glipizide—Decreased appetite—Sibutramine—obesity	0.000102	0.0012	CcSEcCtD
Glipizide—Gastrointestinal disorder—Sibutramine—obesity	0.000101	0.00119	CcSEcCtD
Glipizide—Shock—Bupropion—obesity	0.000101	0.00118	CcSEcCtD
Glipizide—Constipation—Sibutramine—obesity	0.0001	0.00118	CcSEcCtD
Glipizide—Pain—Sibutramine—obesity	0.0001	0.00118	CcSEcCtD
Glipizide—Thrombocytopenia—Bupropion—obesity	0.0001	0.00117	CcSEcCtD
Glipizide—Feeling abnormal—Orlistat—obesity	9.99e-05	0.00117	CcSEcCtD
Glipizide—Conjunctivitis—Topiramate—obesity	9.93e-05	0.00116	CcSEcCtD
Glipizide—Gastrointestinal pain—Orlistat—obesity	9.91e-05	0.00116	CcSEcCtD
Glipizide—Hyperhidrosis—Bupropion—obesity	9.88e-05	0.00116	CcSEcCtD
Glipizide—Anorexia—Bupropion—obesity	9.75e-05	0.00114	CcSEcCtD
Glipizide—Feeling abnormal—Sibutramine—obesity	9.67e-05	0.00113	CcSEcCtD
Glipizide—Urticaria—Orlistat—obesity	9.63e-05	0.00113	CcSEcCtD
Glipizide—Gastrointestinal pain—Sibutramine—obesity	9.59e-05	0.00113	CcSEcCtD
Glipizide—Abdominal pain—Orlistat—obesity	9.58e-05	0.00112	CcSEcCtD
Glipizide—Agranulocytosis—Topiramate—obesity	9.53e-05	0.00112	CcSEcCtD
Glipizide—Urticaria—Sibutramine—obesity	9.32e-05	0.00109	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Bupropion—obesity	9.32e-05	0.00109	CcSEcCtD
Glipizide—Abdominal pain—Sibutramine—obesity	9.27e-05	0.00109	CcSEcCtD
Glipizide—Insomnia—Bupropion—obesity	9.25e-05	0.00108	CcSEcCtD
Glipizide—Rhinitis—Topiramate—obesity	9.19e-05	0.00108	CcSEcCtD
Glipizide—Paraesthesia—Bupropion—obesity	9.18e-05	0.00108	CcSEcCtD
Glipizide—Hepatitis—Topiramate—obesity	9.17e-05	0.00108	CcSEcCtD
Glipizide—Hypoaesthesia—Topiramate—obesity	9.12e-05	0.00107	CcSEcCtD
Glipizide—Dyspnoea—Bupropion—obesity	9.12e-05	0.00107	CcSEcCtD
Glipizide—Pharyngitis—Topiramate—obesity	9.1e-05	0.00107	CcSEcCtD
Glipizide—Somnolence—Bupropion—obesity	9.09e-05	0.00107	CcSEcCtD
Glipizide—Dyspepsia—Bupropion—obesity	9e-05	0.00106	CcSEcCtD
Glipizide—Hypersensitivity—Orlistat—obesity	8.93e-05	0.00105	CcSEcCtD
Glipizide—Decreased appetite—Bupropion—obesity	8.89e-05	0.00104	CcSEcCtD
Glipizide—Visual impairment—Topiramate—obesity	8.84e-05	0.00104	CcSEcCtD
Glipizide—Gastrointestinal disorder—Bupropion—obesity	8.83e-05	0.00104	CcSEcCtD
Glipizide—Pain—Bupropion—obesity	8.74e-05	0.00103	CcSEcCtD
Glipizide—Constipation—Bupropion—obesity	8.74e-05	0.00103	CcSEcCtD
Glipizide—Asthenia—Orlistat—obesity	8.7e-05	0.00102	CcSEcCtD
Glipizide—Hypersensitivity—Sibutramine—obesity	8.64e-05	0.00101	CcSEcCtD
Glipizide—Pruritus—Orlistat—obesity	8.57e-05	0.00101	CcSEcCtD
Glipizide—Eye disorder—Topiramate—obesity	8.57e-05	0.00101	CcSEcCtD
Glipizide—Flushing—Topiramate—obesity	8.51e-05	0.000998	CcSEcCtD
Glipizide—Feeling abnormal—Bupropion—obesity	8.43e-05	0.000988	CcSEcCtD
Glipizide—Asthenia—Sibutramine—obesity	8.41e-05	0.000987	CcSEcCtD
Glipizide—Gastrointestinal pain—Bupropion—obesity	8.36e-05	0.000981	CcSEcCtD
Glipizide—Pruritus—Sibutramine—obesity	8.3e-05	0.000973	CcSEcCtD
Glipizide—Diarrhoea—Orlistat—obesity	8.29e-05	0.000973	CcSEcCtD
Glipizide—Chills—Topiramate—obesity	8.23e-05	0.000965	CcSEcCtD
Glipizide—Urticaria—Bupropion—obesity	8.12e-05	0.000953	CcSEcCtD
Glipizide—Abdominal pain—Bupropion—obesity	8.08e-05	0.000948	CcSEcCtD
Glipizide—Diarrhoea—Sibutramine—obesity	8.02e-05	0.000941	CcSEcCtD
Glipizide—Dizziness—Orlistat—obesity	8.01e-05	0.00094	CcSEcCtD
Glipizide—Erythema—Topiramate—obesity	7.98e-05	0.000936	CcSEcCtD
Glipizide—Flatulence—Topiramate—obesity	7.87e-05	0.000923	CcSEcCtD
Glipizide—Tension—Topiramate—obesity	7.83e-05	0.000919	CcSEcCtD
Glipizide—Dizziness—Sibutramine—obesity	7.76e-05	0.00091	CcSEcCtD
Glipizide—Nervousness—Topiramate—obesity	7.75e-05	0.000909	CcSEcCtD
Glipizide—Vomiting—Orlistat—obesity	7.71e-05	0.000904	CcSEcCtD
Glipizide—Muscle spasms—Topiramate—obesity	7.67e-05	0.0009	CcSEcCtD
Glipizide—Rash—Orlistat—obesity	7.64e-05	0.000896	CcSEcCtD
Glipizide—Dermatitis—Orlistat—obesity	7.63e-05	0.000896	CcSEcCtD
Glipizide—Headache—Orlistat—obesity	7.59e-05	0.000891	CcSEcCtD
Glipizide—Hypersensitivity—Bupropion—obesity	7.53e-05	0.000884	CcSEcCtD
Glipizide—Vision blurred—Topiramate—obesity	7.52e-05	0.000882	CcSEcCtD
Glipizide—Tremor—Topiramate—obesity	7.48e-05	0.000877	CcSEcCtD
Glipizide—Vomiting—Sibutramine—obesity	7.46e-05	0.000875	CcSEcCtD
Glipizide—Ill-defined disorder—Topiramate—obesity	7.41e-05	0.000869	CcSEcCtD
Glipizide—Rash—Sibutramine—obesity	7.4e-05	0.000867	CcSEcCtD
Glipizide—Dermatitis—Sibutramine—obesity	7.39e-05	0.000867	CcSEcCtD
Glipizide—Headache—Sibutramine—obesity	7.35e-05	0.000862	CcSEcCtD
Glipizide—Asthenia—Bupropion—obesity	7.34e-05	0.000861	CcSEcCtD
Glipizide—Pruritus—Bupropion—obesity	7.23e-05	0.000849	CcSEcCtD
Glipizide—Nausea—Orlistat—obesity	7.2e-05	0.000844	CcSEcCtD
Glipizide—Malaise—Topiramate—obesity	7.2e-05	0.000844	CcSEcCtD
Glipizide—Vertigo—Topiramate—obesity	7.17e-05	0.000841	CcSEcCtD
Glipizide—Syncope—Topiramate—obesity	7.16e-05	0.00084	CcSEcCtD
Glipizide—Leukopenia—Topiramate—obesity	7.14e-05	0.000838	CcSEcCtD
Glipizide—Loss of consciousness—Topiramate—obesity	7.02e-05	0.000823	CcSEcCtD
Glipizide—Diarrhoea—Bupropion—obesity	7e-05	0.000821	CcSEcCtD
Glipizide—Nausea—Sibutramine—obesity	6.97e-05	0.000817	CcSEcCtD
Glipizide—Hypertension—Topiramate—obesity	6.89e-05	0.000808	CcSEcCtD
Glipizide—Arthralgia—Topiramate—obesity	6.8e-05	0.000797	CcSEcCtD
Glipizide—Myalgia—Topiramate—obesity	6.8e-05	0.000797	CcSEcCtD
Glipizide—Anxiety—Topiramate—obesity	6.77e-05	0.000794	CcSEcCtD
Glipizide—Dizziness—Bupropion—obesity	6.76e-05	0.000793	CcSEcCtD
Glipizide—Discomfort—Topiramate—obesity	6.71e-05	0.000788	CcSEcCtD
Glipizide—Confusional state—Topiramate—obesity	6.57e-05	0.000771	CcSEcCtD
Glipizide—Oedema—Topiramate—obesity	6.51e-05	0.000764	CcSEcCtD
Glipizide—Vomiting—Bupropion—obesity	6.5e-05	0.000763	CcSEcCtD
Glipizide—Rash—Bupropion—obesity	6.45e-05	0.000756	CcSEcCtD
Glipizide—Dermatitis—Bupropion—obesity	6.44e-05	0.000756	CcSEcCtD
Glipizide—Shock—Topiramate—obesity	6.41e-05	0.000752	CcSEcCtD
Glipizide—Headache—Bupropion—obesity	6.41e-05	0.000751	CcSEcCtD
Glipizide—Thrombocytopenia—Topiramate—obesity	6.38e-05	0.000748	CcSEcCtD
Glipizide—Hyperhidrosis—Topiramate—obesity	6.3e-05	0.000739	CcSEcCtD
Glipizide—Anorexia—Topiramate—obesity	6.21e-05	0.000728	CcSEcCtD
Glipizide—Nausea—Bupropion—obesity	6.07e-05	0.000712	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Topiramate—obesity	5.94e-05	0.000696	CcSEcCtD
Glipizide—Insomnia—Topiramate—obesity	5.89e-05	0.000691	CcSEcCtD
Glipizide—Paraesthesia—Topiramate—obesity	5.85e-05	0.000686	CcSEcCtD
Glipizide—Glyburide—ALB—obesity	5.85e-05	0.0786	CrCbGaD
Glipizide—Dyspnoea—Topiramate—obesity	5.81e-05	0.000681	CcSEcCtD
Glipizide—Somnolence—Topiramate—obesity	5.79e-05	0.000679	CcSEcCtD
Glipizide—Dyspepsia—Topiramate—obesity	5.73e-05	0.000673	CcSEcCtD
Glipizide—Decreased appetite—Topiramate—obesity	5.66e-05	0.000664	CcSEcCtD
Glipizide—Gastrointestinal disorder—Topiramate—obesity	5.62e-05	0.00066	CcSEcCtD
Glipizide—Constipation—Topiramate—obesity	5.57e-05	0.000653	CcSEcCtD
Glipizide—Pain—Topiramate—obesity	5.57e-05	0.000653	CcSEcCtD
Glipizide—Feeling abnormal—Topiramate—obesity	5.37e-05	0.00063	CcSEcCtD
Glipizide—Gastrointestinal pain—Topiramate—obesity	5.33e-05	0.000625	CcSEcCtD
Glipizide—Urticaria—Topiramate—obesity	5.18e-05	0.000607	CcSEcCtD
Glipizide—Abdominal pain—Topiramate—obesity	5.15e-05	0.000604	CcSEcCtD
Glipizide—Hypersensitivity—Topiramate—obesity	4.8e-05	0.000563	CcSEcCtD
Glipizide—Asthenia—Topiramate—obesity	4.67e-05	0.000548	CcSEcCtD
Glipizide—Pruritus—Topiramate—obesity	4.61e-05	0.000541	CcSEcCtD
Glipizide—Diarrhoea—Topiramate—obesity	4.46e-05	0.000523	CcSEcCtD
Glipizide—Dizziness—Topiramate—obesity	4.31e-05	0.000505	CcSEcCtD
Glipizide—Vomiting—Topiramate—obesity	4.14e-05	0.000486	CcSEcCtD
Glipizide—Rash—Topiramate—obesity	4.11e-05	0.000482	CcSEcCtD
Glipizide—Dermatitis—Topiramate—obesity	4.1e-05	0.000481	CcSEcCtD
Glipizide—Headache—Topiramate—obesity	4.08e-05	0.000479	CcSEcCtD
Glipizide—Nausea—Topiramate—obesity	3.87e-05	0.000454	CcSEcCtD
Glipizide—PPARG—Metabolism—GPX1—obesity	5.82e-06	9.52e-05	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—TNF—obesity	5.81e-06	9.51e-05	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—POMC—obesity	5.81e-06	9.51e-05	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—INS—obesity	5.78e-06	9.46e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—UCP1—obesity	5.75e-06	9.41e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PNPLA3—obesity	5.75e-06	9.41e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—COX7C—obesity	5.75e-06	9.41e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SLC27A1—obesity	5.73e-06	9.38e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CD36—obesity	5.67e-06	9.27e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—FABP4—obesity	5.62e-06	9.2e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GLUL—obesity	5.62e-06	9.2e-05	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PIK3CD—obesity	5.53e-06	9.06e-05	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ALB—obesity	5.46e-06	8.94e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—DGAT2—obesity	5.45e-06	8.92e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CS—obesity	5.45e-06	8.92e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CPS1—obesity	5.45e-06	8.92e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SUCLA2—obesity	5.45e-06	8.92e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—obesity	5.42e-06	8.86e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—MTHFR—obesity	5.37e-06	8.79e-05	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PIK3CD—obesity	5.37e-06	8.78e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ECHS1—obesity	5.33e-06	8.72e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—HSD11B1—obesity	5.33e-06	8.72e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—UCP2—obesity	5.33e-06	8.72e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—UCP3—obesity	5.33e-06	8.72e-05	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ALB—obesity	5.3e-06	8.67e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PPARA—obesity	5.27e-06	8.62e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ADH1B—obesity	5.24e-06	8.58e-05	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PIK3R1—obesity	5.23e-06	8.55e-05	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—NOS3—obesity	5.23e-06	8.55e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—LIPE—obesity	5.2e-06	8.51e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—MUT—obesity	5.2e-06	8.51e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—APOB—obesity	5.16e-06	8.45e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PPARGC1B—obesity	5.16e-06	8.44e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GPAM—obesity	5.16e-06	8.44e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ACSL1—obesity	5.16e-06	8.44e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—AGT—obesity	5.1e-06	8.35e-05	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—NOS3—obesity	5.07e-06	8.29e-05	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PIK3R1—obesity	5.07e-06	8.29e-05	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—SERPINE1—obesity	5.04e-06	8.26e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PCK1—obesity	5.01e-06	8.2e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—FADS1—obesity	5.01e-06	8.2e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—HADH—obesity	5.01e-06	8.2e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—APOE—obesity	5e-06	8.18e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYB5A—obesity	4.99e-06	8.16e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—DGAT1—obesity	4.99e-06	8.16e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CAV1—obesity	4.95e-06	8.11e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—APOA1—obesity	4.94e-06	8.09e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—LPL—obesity	4.93e-06	8.07e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ACP5—obesity	4.87e-06	7.97e-05	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PIK3CB—obesity	4.82e-06	7.89e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—obesity	4.81e-06	7.87e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ACLY—obesity	4.8e-06	7.86e-05	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PTGS2—obesity	4.78e-06	7.82e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—G6PD—obesity	4.75e-06	7.77e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—obesity	4.73e-06	7.74e-05	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—IL6—obesity	4.69e-06	7.68e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—HK1—obesity	4.69e-06	7.68e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SREBF2—obesity	4.69e-06	7.68e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CD36—obesity	4.69e-06	7.67e-05	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PIK3CB—obesity	4.68e-06	7.65e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ALOX12—obesity	4.64e-06	7.59e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ENPP1—obesity	4.64e-06	7.59e-05	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PTGS2—obesity	4.63e-06	7.58e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—LPA—obesity	4.53e-06	7.41e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PIK3CG—obesity	4.51e-06	7.38e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HMGCS1—obesity	4.49e-06	7.35e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—LPIN1—obesity	4.43e-06	7.26e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ACADM—obesity	4.36e-06	7.13e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ANGPTL4—obesity	4.36e-06	7.13e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PLIN1—obesity	4.36e-06	7.13e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PFKFB3—obesity	4.36e-06	7.13e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PNPLA2—obesity	4.36e-06	7.13e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SAT1—obesity	4.36e-06	7.13e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—obesity	4.36e-06	7.13e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—APOA5—obesity	4.34e-06	7.11e-05	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—AKT1—obesity	4.33e-06	7.08e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—POMC—obesity	4.29e-06	7.03e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—INS—obesity	4.27e-06	6.99e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYTB—obesity	4.24e-06	6.94e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—OXCT1—obesity	4.24e-06	6.94e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ACACB—obesity	4.24e-06	6.94e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—obesity	4.22e-06	6.9e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SLC22A1—obesity	4.14e-06	6.78e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CLOCK—obesity	4.14e-06	6.78e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—obesity	4.13e-06	6.77e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PNLIP—obesity	4.13e-06	6.76e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SRD5A1—obesity	4.13e-06	6.76e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—obesity	4.1e-06	6.7e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—obesity	4.09e-06	6.69e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SULT2A1—obesity	4.04e-06	6.61e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GLP1R—obesity	4.04e-06	6.61e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SDC3—obesity	4.03e-06	6.6e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—DPYD—obesity	3.97e-06	6.5e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PIK3CD—obesity	3.97e-06	6.49e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—STS—obesity	3.94e-06	6.45e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYP26B1—obesity	3.94e-06	6.45e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HK2—obesity	3.94e-06	6.45e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ALB—obesity	3.92e-06	6.41e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PPARD—obesity	3.86e-06	6.31e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PRKAR2B—obesity	3.82e-06	6.26e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—DCN—obesity	3.8e-06	6.21e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SLC27A1—obesity	3.78e-06	6.19e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PIK3R1—obesity	3.74e-06	6.13e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—NOS3—obesity	3.74e-06	6.13e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—obesity	3.73e-06	6.11e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—FABP4—obesity	3.71e-06	6.07e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GLUL—obesity	3.71e-06	6.07e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CPT1A—obesity	3.69e-06	6.04e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—NAMPT—obesity	3.62e-06	5.93e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—obesity	3.6e-06	5.89e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—LIPC—obesity	3.6e-06	5.89e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GCK—obesity	3.6e-06	5.89e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—APOC3—obesity	3.58e-06	5.85e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—obesity	3.55e-06	5.81e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ECHS1—obesity	3.51e-06	5.75e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HSD11B1—obesity	3.51e-06	5.75e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—UCP3—obesity	3.51e-06	5.75e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—UCP2—obesity	3.51e-06	5.75e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CETP—obesity	3.47e-06	5.68e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ADH1B—obesity	3.46e-06	5.66e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PIK3CB—obesity	3.46e-06	5.66e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SDC1—obesity	3.43e-06	5.62e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PTGS2—obesity	3.43e-06	5.61e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ACSL1—obesity	3.4e-06	5.57e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PPARGC1B—obesity	3.4e-06	5.57e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GPAM—obesity	3.4e-06	5.57e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—AKR1C3—obesity	3.38e-06	5.53e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SCARB1—obesity	3.33e-06	5.44e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PCK1—obesity	3.3e-06	5.41e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HADH—obesity	3.3e-06	5.41e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—FADS1—obesity	3.3e-06	5.41e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—obesity	3.28e-06	5.37e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—obesity	3.24e-06	5.3e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SREBF1—obesity	3.23e-06	5.28e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ACP5—obesity	3.21e-06	5.26e-05	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—MYC—obesity	3.19e-06	5.22e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GOT2—obesity	3.14e-06	5.14e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—G6PD—obesity	3.13e-06	5.13e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—obesity	3.1e-06	5.07e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HK1—obesity	3.09e-06	5.06e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SREBF2—obesity	3.09e-06	5.06e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—FASN—obesity	3.07e-06	5.03e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—BCHE—obesity	3.06e-06	5.01e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—LPA—obesity	2.99e-06	4.89e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CYP2E1—obesity	2.95e-06	4.83e-05	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PIK3CA—obesity	2.94e-06	4.81e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—LPIN1—obesity	2.92e-06	4.79e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—NQO1—obesity	2.92e-06	4.78e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—APOA5—obesity	2.86e-06	4.69e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—obesity	2.86e-06	4.68e-05	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PIK3CA—obesity	2.85e-06	4.67e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—obesity	2.83e-06	4.64e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GCG—obesity	2.8e-06	4.58e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SLC2A4—obesity	2.8e-06	4.58e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CYCS—obesity	2.76e-06	4.52e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SLC22A1—obesity	2.73e-06	4.47e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CLOCK—obesity	2.73e-06	4.47e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GGT1—obesity	2.71e-06	4.44e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GOT1—obesity	2.71e-06	4.44e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—NCOA1—obesity	2.67e-06	4.37e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SULT2A1—obesity	2.66e-06	4.36e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GLP1R—obesity	2.66e-06	4.36e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—STK11—obesity	2.63e-06	4.31e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CYP19A1—obesity	2.63e-06	4.31e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—DPYD—obesity	2.62e-06	4.29e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PRKAR2B—obesity	2.52e-06	4.13e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—DCN—obesity	2.5e-06	4.1e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—COMT—obesity	2.45e-06	4e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CPT1A—obesity	2.44e-06	3.99e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GNB3—obesity	2.41e-06	3.95e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PPARGC1A—obesity	2.41e-06	3.95e-05	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—AKT1—obesity	2.4e-06	3.93e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—HMOX1—obesity	2.4e-06	3.93e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—NAMPT—obesity	2.39e-06	3.91e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—LIPC—obesity	2.37e-06	3.88e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GCK—obesity	2.37e-06	3.88e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—APOC3—obesity	2.36e-06	3.86e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GNAS—obesity	2.35e-06	3.84e-05	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—AKT1—obesity	2.33e-06	3.81e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—APOB—obesity	2.3e-06	3.76e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CETP—obesity	2.29e-06	3.75e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SDC1—obesity	2.26e-06	3.71e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—AKR1C3—obesity	2.23e-06	3.65e-05	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—AKT1—obesity	2.21e-06	3.62e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—LPL—obesity	2.2e-06	3.59e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SCARB1—obesity	2.19e-06	3.59e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GPX1—obesity	2.14e-06	3.51e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SREBF1—obesity	2.13e-06	3.48e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PIK3CA—obesity	2.11e-06	3.45e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CD36—obesity	2.09e-06	3.42e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GOT2—obesity	2.07e-06	3.39e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—FASN—obesity	2.03e-06	3.32e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—BCHE—obesity	2.02e-06	3.3e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—MTHFR—obesity	1.98e-06	3.24e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYP2E1—obesity	1.95e-06	3.19e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PPARA—obesity	1.94e-06	3.17e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—NQO1—obesity	1.93e-06	3.15e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—AGT—obesity	1.88e-06	3.07e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GCG—obesity	1.85e-06	3.02e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SLC2A4—obesity	1.85e-06	3.02e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—APOE—obesity	1.84e-06	3.01e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CAV1—obesity	1.82e-06	2.99e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYCS—obesity	1.82e-06	2.98e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—APOA1—obesity	1.82e-06	2.98e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GOT1—obesity	1.79e-06	2.93e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GGT1—obesity	1.79e-06	2.93e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—NCOA1—obesity	1.76e-06	2.88e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.74e-06	2.85e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYP19A1—obesity	1.74e-06	2.84e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—STK11—obesity	1.74e-06	2.84e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—AKT1—obesity	1.72e-06	2.82e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PIK3CG—obesity	1.66e-06	2.72e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—COMT—obesity	1.61e-06	2.64e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PPARG—obesity	1.6e-06	2.62e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GNB3—obesity	1.59e-06	2.6e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PPARGC1A—obesity	1.59e-06	2.6e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HMOX1—obesity	1.58e-06	2.59e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—POMC—obesity	1.58e-06	2.59e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—INS—obesity	1.57e-06	2.57e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GNAS—obesity	1.55e-06	2.54e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—APOB—obesity	1.52e-06	2.48e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PIK3CD—obesity	1.46e-06	2.39e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—LPL—obesity	1.45e-06	2.37e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ALB—obesity	1.44e-06	2.36e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GPX1—obesity	1.41e-06	2.31e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PIK3R1—obesity	1.38e-06	2.26e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—NOS3—obesity	1.38e-06	2.26e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CD36—obesity	1.38e-06	2.25e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—MTHFR—obesity	1.3e-06	2.13e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PPARA—obesity	1.28e-06	2.09e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PIK3CB—obesity	1.27e-06	2.08e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PTGS2—obesity	1.26e-06	2.06e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—AGT—obesity	1.24e-06	2.03e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—APOE—obesity	1.21e-06	1.99e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CAV1—obesity	1.2e-06	1.97e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—APOA1—obesity	1.2e-06	1.96e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PIK3CG—obesity	1.1e-06	1.79e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PPARG—obesity	1.06e-06	1.73e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—POMC—obesity	1.04e-06	1.71e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—INS—obesity	1.04e-06	1.7e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PIK3CD—obesity	9.63e-07	1.58e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ALB—obesity	9.51e-07	1.56e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PIK3R1—obesity	9.1e-07	1.49e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—NOS3—obesity	9.1e-07	1.49e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PIK3CB—obesity	8.4e-07	1.37e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PTGS2—obesity	8.32e-07	1.36e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PIK3CA—obesity	7.76e-07	1.27e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—AKT1—obesity	6.34e-07	1.04e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PIK3CA—obesity	5.12e-07	8.38e-06	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—AKT1—obesity	4.18e-07	6.84e-06	CbGpPWpGaD
